Single tumor-initiating cells evade immune clearance by recruiting type II macrophages

Xiaocan Guo1, Yang Zhao1, Huan Yan1

  • 1Life Sciences Institute, Innovation Center for Cell Signaling Network, Zhejiang University, Hangzhou, Zhejiang 310058, China.

Genes & Development
|February 23, 2017
PubMed

Insights

Tumor-initiating cells (TICs) actively recruit M2 macrophages, crucial for early liver tumor development. Eliminating these tumor-associated macrophages (TICAMs) prevents tumor formation, highlighting YAP as a therapeutic target.

Area of Science:

  • Hepatology
  • Immunology
  • Oncology

Background:

  • M2 macrophages promote tumor growth by hindering immune clearance, boosting proliferation, and stimulating angiogenesis.
  • Macrophages accumulate near liver tumor-initiating cells (TICs), but their recruitment and role in tumor initiation are unclear.

Purpose of the Study:

  • To investigate if and how TICs recruit macrophages.
  • To determine the function of these macrophages in liver tumor initiation.

Main Methods:

  • Generation of genetically defined liver TICs.
  • Elimination of TIC-associated macrophages (TICAMs) to assess tumorigenesis.
  • Investigating the role of the Hippo pathway effector YAP in macrophage recruitment.

Main Results:

  • TICs actively recruit M2 macrophages starting from the single-cell stage.
  • Elimination of TICAMs abolished tumorigenesis, dependent on the immune system.
  • Activation of YAP in TICs drives M2 macrophage recruitment.

Conclusions:

  • Macrophages are essential for the survival of single TICs in vivo.
  • Targeting YAP or M2 macrophages offers a therapeutic strategy for TIC elimination and liver cancer prevention.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.2K